Discovery of naphthyl‐N‐acylhydrazone p38α MAPK inhibitors with in vivo anti‐inflammatory and anti‐TNF‐α activity
Publisher: John Wiley & Sons Inc
E-ISSN: 1747-0285|91|2|391-397
ISSN: 1747-0277
Source: CHEMICAL BIOLOGY & DRUG DESIGN (ELECTRONIC), Vol.91, Iss.2, 2018-02, pp. : 391-397
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract